title: [Candesartan reduces the risk of mortality and recurrence of chronic heart failure. Important results from the CHARM study].
authors.affiliation: Karolinska institutet, Danderyds sjukhus.
authors.forename: Hans
authors.initials: H
authors.lastname: Persson
authors.forename: Karl
authors.initials: K
authors.lastname: Swedberg
mesh_terms: D057912:Angiotensin II Type 2 Receptor Blockers; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D001562:Benzimidazoles / Q000627:therapeutic use*; D001713:Biphenyl Compounds; D006333:Heart Failure / Q000188:drug therapy* / Q000401:mortality; D006801:Humans; D016032:Randomized Controlled Trials as Topic; D012008:Recurrence; D012307:Risk Factors; D013777:Tetrazoles / Q000627:therapeutic use*
chemical_list: D057912:Angiotensin II Type 2 Receptor Blockers; D000959:Antihypertensive Agents; D001562:Benzimidazoles; D001713:Biphenyl Compounds; D013777:Tetrazoles; C081643:candesartan